Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 13, 2021

SELL
$65.74 - $169.86 $398,384 - $1.03 Million
-6,060 Closed
0 $0
Q4 2019

Jan 14, 2020

BUY
$13.93 - $21.28 $84,415 - $128,956
6,060 New
6,060 $119,000
Q2 2019

Jul 11, 2019

SELL
$13.7 - $28.34 $83,022 - $171,740
-6,060 Closed
0 $0
Q1 2019

Apr 09, 2019

BUY
$14.45 - $23.7 $87,567 - $143,622
6,060 New
6,060 $123,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Acropolis Investment Management, LLC Portfolio

Follow Acropolis Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.